There is growing evidence that E-cadherin plays a crucial role in the invasion and metastasis of human cancer, including genital and urinary cancers, indicating that E-cadherin could be a promising therapeutic target for designing anti-tumor drugs. This evidence concerns the gene CDH1 and neoplasm.